-
<![CDATA[Nogapendekin Alfa Inbakicept Plus Checkpoint Inhibition Leads to Immune Restoration in NSCLC]]>
15 Jan 2026 04:39 GMT
… patients with checkpoint inhibitor–resistant NSCLC in the confirmatory phase … second- or later-line NSCLC.
Enrolled patients received nogapendekin …
Nogapendekin alfa inbakicept for advanced non-small cell lung cancer. ClinicalTrials.gov. Updated October …
-
<![CDATA[Widespread Reflex Testing Closes Molecular Testing Gaps in NSCLC]]>
15 Jan 2026 04:39 GMT
… non–small cell lung cancer (NSCLC), widespread comprehensive molecular testing starting … ’ molecular testing methodologies for NSCLC and discussed how they might … patients with advanced non-squamous non-small cell lung cancer (NSCLC). J Thorac Oncol. 2021; …
-
Spherix Global Insights Highlights Evolving PD-1 Landscape as Subcutaneous Use Grows and Biosimilars Approach across Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
14 Jan 2026 14:09 GMT
… eventual shift toward biosimilars across non-small cell lung cancer (NSCLC), melanoma, and renal cell carcinoma … to be strongly preferred in NSCLC and melanoma, driven by established …
-
<![CDATA[Frontline Osimertinib Combo Prolongs Survival in Advanced EGFR+ NSCLC]]>
14 Jan 2026 22:04 GMT
… with EGFR-mutated advanced NSCLC.”
In the international, … older with pathologically confirmed nonsquamous NSCLC; newly diagnosed locally advanced … mutated epidermal growth factor receptor non-small cell lung cancer (FLAURA2) (FLAURA2). ClinicalTrials. …
-
TROPION-Lung17 TROP2 Biomarker Directed Phase 3 Trial of DATROWAY® Initiated in Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer
13 Jan 2026 12:15 GMT
… locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) without actionable genomic alterations previously … Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
TROPION-Lung05, TROPION-Lung01, TROPION …
-
Advancing Precision Medicine in Non-Small Cell Lung Cancer Diagnostics in a Southeast Asian Country
13 Jan 2026 09:37 GMT
Introduction
Non-small cell lung cancer (NSCLC) accounts for a significant … generation sequencing for treatment in non-small cell lung cancer patients: the observational, … (NGS) in an Asian non-small cell lung cancer (NSCLC) population: incremental yield of …
-
<![CDATA[Widespread NGS Accessibility Is Crucial to Offering Ideal Treatment in NSCLC]]>
14 Jan 2026 16:43 GMT
… on operationalizing screening in NSCLC, Carbone and Reinmuth discussed … biomarker testing across the NSCLC spectrum, approaches to streamlining … Testing and Screening in NSCLC
Insufficient biopsies remain an … in guiding treatment in NSCLC. “We test every …
-
<![CDATA[Nogapendekin Alfa Inbakicept Shows Promise in Checkpoint-Refractory NSCLC]]>
14 Jan 2026 15:29 GMT
… focused on patients with metastatic NSCLC whose disease had progressed … with docetaxel in second-line NSCLC.3
REFERENCES
1. ImmunityBio announces … combination with checkpoint inhibitors in non-small cell lung cancer. News release. ImmunityBio. January13, …
-
Fast Five Quiz: NSCLC and PD-L1
14 Jan 2026 15:19 GMT
… several different cancers, including non-small cell lung cancer (NSCLC). Several approved therapies and … guide treatment decisions in NSCLC. International guidelines recommend testing … the pathophysiology of NSCLC.
Patients with NSCLC harboring BRAF mutations …
-
<![CDATA[Patient Case #2: Newly Diagnosed Stage 3B NSCLC]]>
14 Jan 2026 15:29 GMT
… non–small cell lung cancer (NSCLC) requiring integrating imaging, laboratory results … for patients with early-stage NSCLC.
About
© 1995-2026